Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab

Saved in:
Bibliographic Details
Published in:Annals of hematology 2022-12, Vol.101 (12), p.2795-2797
Main Authors: Masamoto, Yosuke, Taoka, Kazuki, Maki, Hiroaki, Kurokawa, Mineo
Format: Article
Language:English
Subjects:
Hematology
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-022-04987-5